ROARABLE
FREE $100K
My Trading Account →
▾
Trading Profile Active
Active Trader
Verified Trader
⚡ My $100K Trading Account → ★ My Saved Watchlist →
🟢 My $100K Account → Today Screener Big Ideas Track Record 💰 $100K Arena 🎲 Predictions 🏛️ Insiders 8 Analysts
Stock Ratings / Consumer Discretionary / EVH / news
CSV (56) BLW (43) EVI (59) KLC (24) ⌘ Pro Terminal →

Why EVH Stock dropped -3.37% Today — RQD Quant Desk Flash

$4.30 -3.37% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $4.27

Evolent Health Inc (Class A) (EVH) carries a Roarable Rating of D- (Sell) with 43/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D- • SELL / AVOID Cap $503.1M
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on EVH Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is EVH stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-03, Evolent Health Inc (Class A) (NYSE: EVH) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 43/100 at a spot price of $4.30 (-3.37% 1D, market cap $503.1M). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 10/20, SEC Balance-Sheet Forensics 6/20, FRED Macro Regime Fit 10/20, and Executive Insider Alignment 9/20. Across 1009 tracked Consumer Discretionary issuers, EVH ranks #687 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does EVH compare to CSV and BLW in the Consumer Discretionary sector?
▼

Within the Consumer Discretionary sector (Other Consumer Services), EVH carries a Roarable D- (43/100 RQD), trailing P/E of N/A, gross margin of 21.3%, and ROIC of -26.3%. By comparison, CSV (Carriage Services Inc.) holds a D+ grade (56/100 RQD, P/E 10.9x, ROIC 29.8%, cap $555.1M) and BLW (Blackrock Limited Duration Income Trust) posts a D- grade (43/100 RQD, P/E N/A, ROIC —, cap $415.3M). Among the 5-stock peer group, CSV leads on earnings multiple (10.9x) while CSV leads on capital efficiency (29.8% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for EVH?
▼

Per EVH's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001628908), Evolent Health Inc (Class A) generated $1.88B in revenue (-26.6% YoY), -$579.4M in net income, and $38.8M in free cash flow against $1.90B in total assets and $970.5M in total debt. Key quantitative strengths: Established market leader in Consumer Discretionary with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $4.27 (-0.80%)🧬 Disciplined Float (-0.40% YoY Shares)⚙️ Cash Engine: 8/20 (D-) • 2.1% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record Warning: Scores below 50 (43/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-6.7% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →
RQD QUANT TACHOMETERSELL / AVOID • D-
025507510043
3-of-3 Quant Analysts Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR RQD RADARRw D · Rk D-
Cash (8)Whales (10)SEC (6)Macro (10)CEO (9)
Each axis scored 0–20
12M PRICE TARGET CONE-6.7% Base Target
$7 Bull$4 Base$3 Bear
📬 FREE EVH RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for EVH)Realized 20D OHLCV Swing Band: ±12.4%
Deterministic 5-Pillar Attribution (43/100 Composite)
🔍 WHY EVH SCORES 43/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Whale & Options Positioning+10/20 pts (23% of score)

20D Institutional Volume Accumulation (±12.4% realized swing band)

▲ #2 Bullish Driver: Macro Regime Fit+10/20 pts (23% of score)

FRED Regime × Technicals: 46% of 52W Range • RSI-14 at 53.6 (NEUTRAL RANGE)

▼ #1 Drag / Risk Factor: SEC 10-K Forensic Risk6/20 pts (-14 pt drag)

Balance-sheet & 10-K footnote risk deducts 14 pts from forensic ceiling

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
51
Grade C-$4.73+2.1% Next Q
Q2 (-2Q)
48
Grade D$4.83-10.4% Next Q
Q3 (-1Q)
46
Grade D$4.33-0.7% Next Q
Current
43
Grade D-$4.30-6.7% Hist 90D α
Trajectory: C- (51) → D- (43)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a EVH Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While EVH currently carries a cautious 43/100 (D-) rating due to SEC 10-K Forensic Risk (6/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Consumer Discretionary with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($4.17) and Max Pain ($4.52) forces dealer call-delta covering toward $7.23.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (-0.40% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $EVH• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “EVH Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
YES 43%NO 57%Trade / Inspect Odds →
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →

Why EVH Stock dropped -3.37% Today — RQD Quant Desk Flash

Evolent Health Inc (Class A) (EVH) dropped -3.37% to $4.30, trading at 46% of its 52-week range ($2.1 – $6.89). Stretched risk/reward at current multiples (-26% return on capital) under elevated 10-year interest-rate pressure.

  • ▸Technical Tape: Trading at 46% of its 52-week range ($2.1 – $6.89) with RSI-14 at 53.6 (NEUTRAL RANGE).
  • ▸Volatility Profile: Historical 20-day realized swing band of ±12.4% around $4.30 (no active unusual options sweep snapshot on file).
  • ▸Fundamental Anchor: Roarable D- (Sell) backed by 21.3% gross margin and $38.8M annual free cash flow.
Live EVH Headlines & Catalysts
RISK WATCHStockStory • 2d ago
3 Value Stocks with Warning Signs

StockStory report covering Evolent Health Inc (Class A) (EVH) market action, institutional positioning, and fundamental catalysts.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring EVH)

  • ✓Walkthrough of EVH's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
Join Founding VIP Waitlist (No Card Required) →$100K Arena
EVH // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +9.97%▲ ASCENDING CHANNEL
2026-11-04O $4.30H $4.45L $4.30C $4.30VOL 1.43M
RES: $5.14SUP: $3.51SMA50: $4.17SMA200: $3.88
$6.49$5.53$4.56$3.60$2.63RES $5.14SUP $3.51$4.302026-05-052026-06-182026-08-052026-09-212026-11-04
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

EVH Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 EVH Butterfly Map → + Track EVH →
Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle
8.0%/yr Implied 5Y Growth

vs. -26.6% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on EVH today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for EVH. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for EVH today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (EVH)

Consumer Discretionary Rank #687 of 1009 ⚔️ CSV vs EVH Full Matrix →

1. Head-to-Head Consumer Discretionary Peer Comparison (EVH vs. CSV, BLW, EVI, KLC)

Industry: Other Consumer Services (73 Tracked Issuers)

Across 1009 tracked Consumer Discretionary securities in the Roarable RQD universe, Evolent Health Inc (Class A) (EVH) ranks #687 by composite RQD confidence (43/100, grade D-) and #585 by equity capitalization ($503.1M). Within this direct 5-issuer industry benchmark cohort, CSV leads on earnings valuation at 10.9x trailing P/E, while CSV leads on capital efficiency and profitability with 29.8% ROIC and 35.1% gross margin. EVI currently holds the highest overall quantitative score in the immediate peer group at 59/100 (C-) compared with EVH at 43/100 (D-).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
EVH ACTIVE
Evolent Health Inc (Class A)
D- 43/100 — 21.3% -26.3% -3.37% $503.1M Benchmark Subject
CSV
Carriage Services Inc.
D+ 56/100 10.9x 35.1% 29.8% -1.97% $555.1M /csv-vs-evh →
BLW
Blackrock Limited Duration Income Trust
D- 43/100 — — — +0.09% $415.3M /blw-vs-evh →
EVI
EVI Industries Inc.
C- 59/100 37.3x 30.4% 5.4% -0.27% $284.6M /evi-vs-evh →
KLC
KinderCare Learning Companies Inc.
E 24/100 — — -1.0% +0.49% $243.0M /klc-vs-evh →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001628908 ↗

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Evolent Health Inc (Class A) (EVH) reported GAAP revenue of $1.88B (-26.6% vs. FY2024 revenue of $2.55B , and -4.5% cumulative change since FY2023) , GAAP net income of -$579.4M, operating cash flow of $38.8M, and free cash flow of $38.8M (+107.0% YoY). On the balance sheet, EVH closed FY2025 with $1.90B in total assets against $970.5M in total debt (Altman Z-Score: 0.20, Piotroski F-Score: 4/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $1.88B -$579.4M $38.8M $38.8M $1.90B $970.5M
FY2024 (FY) 2024-12-31 $2.55B -$93.5M $18.8M $18.8M $2.54B $490.5M
FY2023 (FY) 2023-12-31 $1.96B -$142.3M $142.6M $142.6M — —

3. EVH Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is EVH stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, Evolent Health Inc (Class A) (NYSE: EVH) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 43/100 at a spot price of $4.30 (-3.37% 1D, market cap $503.1M). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 10/20, SEC Balance-Sheet Forensics 6/20, FRED Macro Regime Fit 10/20, and Executive Insider Alignment 9/20. Across 1009 tracked Consumer Discretionary issuers, EVH ranks #687 in composite RQD confidence.

How does EVH compare to CSV and BLW in the Consumer Discretionary sector?

Within the Consumer Discretionary sector (Other Consumer Services), EVH carries a Roarable D- (43/100 RQD), trailing P/E of N/A, gross margin of 21.3%, and ROIC of -26.3%. By comparison, CSV (Carriage Services Inc.) holds a D+ grade (56/100 RQD, P/E 10.9x, ROIC 29.8%, cap $555.1M) and BLW (Blackrock Limited Duration Income Trust) posts a D- grade (43/100 RQD, P/E N/A, ROIC —, cap $415.3M). Among the 5-stock peer group, CSV leads on earnings multiple (10.9x) while CSV leads on capital efficiency (29.8% ROIC).

What are the biggest fundamental strengths and SEC risk factors for EVH?

Per EVH's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001628908), Evolent Health Inc (Class A) generated $1.88B in revenue (-26.6% YoY), -$579.4M in net income, and $38.8M in free cash flow against $1.90B in total assets and $970.5M in total debt. Key quantitative strengths: Established market leader in Consumer Discretionary with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

Where is EVH trading relative to its 50-day, 200-day, and 52-week technical levels?

EVH last traded at $4.30 (-3.37% on volume of 1,262,812 shares), positioning the stock +3.12% above its 50-day simple moving average ($4.17) and +10.82% above its 200-day simple moving average ($3.88). Across its 52-week range of $2.10 to $6.89, EVH sits at the 45.9% percentile with a 14-day RSI of 53.6 (NEUTRAL RANGE) and an implied next-earnings move of ±12.4% ($3.77 to $4.83).

Direct Sub-Reports: EVH RQD Cockpit EVH 12M Forecast EVH Earnings & Move EVH Dividends & DRIP EVH Insiders & 13F EVH Whale Options EVH Profit Sankey EVH News & Why
ROARABLE RATING BRIEF • RQD 43/100 (D-) ✓ SEC XBRL & RQD VERIFIED

EVH — Evolent Health Inc (Class A): What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-12-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

Evolent Health Inc (Class A) (EVH) earns a live Roarable RQD composite score of 43/100, corresponding to a D- letter grade (Roarable Sell) at a spot price of $4.30 (-3.37% 1D, market capitalization $503.1M).

  • Fundamental Cash Engine (8/20): Anchored by return on invested capital (ROIC) of -26.3%, gross margin of 21.3%, operating margin of -21.9%, and free cash flow yield of 8.08%.
  • Whale 13F & Options Flow (10/20) + Insider Conviction (9/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (10/20) + Forensic Balance Sheet (6/20): Incorporates a 1.00x equity beta, Altman Z-Score of 0.20, Piotroski F-Score of 4/9, and Debt/Equity of 2.34x.

2. Business Model, Unit Margins & SEC Financial Trajectory

Evolent Health Inc (Class A) is a NYSE-listed issuer classified under the Consumer Discretionary sector and Other Consumer Services industry, profile.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Evolent Health Inc (Class A) (EVH) reported $1.88B in annual revenue (up from $2.55B in FY2024, -26.6% YoY) and -$579.4M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($1.96B revenue, -$142.3M net income) through FY2025, EVH scaled operating cash flow to $38.8M and free cash flow to $38.8M, backed by $1.90B in total assets against $970.5M in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • 🐂 Primary Bull Case (D- • RQD 43/100): Established market leader in Consumer Discretionary with deep daily trading liquidity. Free cash flow yield of 8.08% and institutional whale pillar of 10/20. With Fundamental Cash Engine at 8/20 and Institutional Whale Flow at 10/20, sustained execution supports upside toward the upper end of the $2.10 – $6.89 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against -21.9% operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

No upstream or downstream dependencies, sector correlations, or proprietary signal links are recorded (supply_chain: NONE; butterfly_links: empty). — for upstream/downstream dependencies or 2nd-order bottlenecks. Investors should note that the absence of mapped links means this dossier cannot identify ripple pathways; the cited sector classification (Consumer Discretionary / Other Consumer Services) is the only structural reference available.

  • Key Question #1: Can EVH sustain or expand its -21.9% operating margin and -26.3% ROIC against Other Consumer Services peers over the next 4 quarters?
  • Key Question #2: Following FY2025 revenue of $1.88B and free cash flow of $38.8M, how will capital allocation balance growth reinvestment against $970.5M in total debt?
  • Key Question #3: How sensitive is EVH's equity valuation to Consumer Discretionary capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

EVH Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Evolent Health Inc (Class A) (EVH) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to EVH Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

EVH Bull vs. Bear Conversation Board — What's Your Call at $4.30?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON EVH 🐻 33% BEARISH CONVICTION
1. Pick Your Side on EVH:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
QU QuantViper RQD DEBATE OPENER • Systematic Momentum Desk 🐂 BULLISH 🎯 Target: $5.25 (+22.1%)
📌 Pinned Debate

Positive 8.08% FCF yield and a reported 8.04 percent single-day gain suggest the market price may undervalue reported free cash flow.

Picked up a starter position in EVH in my $100K Virtual Cash book at $4.30. Positive 8.08% FCF yield and a reported 8.04 percent single-day gain suggest the market price may undervalue reported free cash flow.. Trading inside a $2.10–$6.89 52-week range with 8.08% FCF yield gives solid downside support if Other Consumer Services multiples expand this quarter.

RetailWhale_TX 🐂 BULL

@ForensicBear Shorting a 10/20 institutional whale-flow stock at $4.30 is dangerous when funds are rotating into Consumer Discretionary.

FO ForensicBear RQD DEBATE OPENER • 10-K Footnote Auditor 🐻 BEARISH 🎯 Target: $3.61 (-16.0%)
Spot @ $4.30

Altman Z of 0.2, Debt/Equity of 2.34, and debt rising to $970.5M against $151.9M cash point to acute balance-sheet and solvency risk.

Here is the bear case nobody on the bull side wants to address on EVH: Altman Z of 0.2, Debt/Equity of 2.34, and debt rising to $970.5M against $151.9M cash point to acute balance-sheet and solvency risk.. At current EV/EBITDA multiples, even a small guidance miss in Other Consumer Services triggers a 12-15% air pocket.

LIVE TAPE